Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 16, 2018
Safety evaluation of a human chimeric monoclonal antibody that recognizes the extracellular loop domain of claudin-2
Yosuke Hashimoto, Tomoyuki Hata, Minoru Tada, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 29, 2015
Discovery of anti-claudin-1 antibodies as candidate therapeutics against hepatitis C virus
Mayo Yamashita, Manami Iida, Minoru Tada, et al.
International Journal of Cancer
|
April 29, 2006
Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma
Misuzu Shimakage, Nobumasa Inoue, Kohichi Ohshima, et al.
Biochemical and Biophysical Research Communications
|
June 12, 2016
Generation and characterization of a human-mouse chimeric antibody against the extracellular domain of claudin-1 for cancer therapy using a mouse model
Yosuke Hashimoto, Minoru Tada, Manami Iida, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 4, 2015
Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte Model
Misaki Nakajima, Shotaro Nagase, Manami Iida, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 19, 2017
Claudin-5-Binders Enhance Permeation of Solutes across the Blood-Brain Barrier in a Mammalian Model
Yosuke Hashimoto, Keisuke Shirakura, Yoshiaki Okada, et al.
Scientific Reports
|
November 8, 2017
Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay
Akihiro Watari, Miki Kodaka, Koji Matsuhisa, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 21, 2017
Creation of a Claudin-2 Binder and Its Tight Junction-Modulating Activity in a Human Intestinal Model
Mutsumi Takigawa, Manami Iida, Shotaro Nagase, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 14, 2018
Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system
Satoshi Zeniya, Hiroya Kuwahara, Kaiichi Daizo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 14, 2014
Development of an anti-claudin-3 and -4 bispecific monoclonal antibody for cancer diagnosis and therapy
Xiangru Li, Manami Iida, Minoru Tada, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 16, 2018
Safety evaluation of a human chimeric monoclonal antibody that recognizes the extracellular loop domain of claudin-2
Yosuke Hashimoto, Tomoyuki Hata, Minoru Tada, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 29, 2015
Discovery of anti-claudin-1 antibodies as candidate therapeutics against hepatitis C virus
Mayo Yamashita, Manami Iida, Minoru Tada, et al.
International Journal of Cancer
|
April 29, 2006
Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma
Misuzu Shimakage, Nobumasa Inoue, Kohichi Ohshima, et al.
Biochemical and Biophysical Research Communications
|
June 12, 2016
Generation and characterization of a human-mouse chimeric antibody against the extracellular domain of claudin-1 for cancer therapy using a mouse model
Yosuke Hashimoto, Minoru Tada, Manami Iida, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 4, 2015
Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte Model
Misaki Nakajima, Shotaro Nagase, Manami Iida, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 19, 2017
Claudin-5-Binders Enhance Permeation of Solutes across the Blood-Brain Barrier in a Mammalian Model
Yosuke Hashimoto, Keisuke Shirakura, Yoshiaki Okada, et al.
Scientific Reports
|
November 8, 2017
Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay
Akihiro Watari, Miki Kodaka, Koji Matsuhisa, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 21, 2017
Creation of a Claudin-2 Binder and Its Tight Junction-Modulating Activity in a Human Intestinal Model
Mutsumi Takigawa, Manami Iida, Shotaro Nagase, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 14, 2018
Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system
Satoshi Zeniya, Hiroya Kuwahara, Kaiichi Daizo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 14, 2014
Development of an anti-claudin-3 and -4 bispecific monoclonal antibody for cancer diagnosis and therapy
Xiangru Li, Manami Iida, Minoru Tada, et al.
Page
of 4